Literature DB >> 20591217

A novel sesquiterpene Hirsutanol A induces autophagical cell death in human hepatocellular carcinoma cells by increasing reactive oxygen species.

Fen Yang1, You-Heng Gao, Ke-Wei Wu, Rong Deng, Dan-Dan Li, Zhi-Xiong Wei, Shan Jiang, Xiao-Qi Wu, Gong-Kan Feng, Hou-Jin Li, Xiao-Feng Zhu.   

Abstract

BACKGROUND AND
OBJECTIVE: Hirsutanol A is a novel sesquiterpene compound purified from fungus chondrostereum sp in Sarcophyton tortuosum. Its pharmacologic effect has not been reported yet. This study aimed to investigate cytotoxic effect of Hirsutanol A on hepatocellular carcinoma (HCC) cells and its mechanism.
METHODS: Hep3B cells were treated with different concentrations of Hirsutanol A. Cell proliferation was detected by MTT assay. The protein expression of LC3 was determined by Western blot. The generation of reactive oxygen species (ROS) was monitored by flow cytometry.
RESULTS: Hirsutanol A significantly inhibited proliferation of Hep3B cells with 50% inhibition concentrations (IC50) of 14.54, 6.71, and 3.59 micromol/L when exposed to Hirsutanol A for 24, 48, and 72 h, respectively. Incubation of Hep3B cells with Hirsutanol A markedly increased the level of ROS and the autophagy marker MAP-LC3 conversion from type I to type II. Pre-incubation with an antioxidant N-acetyl cystein (NAC) decreased the level of ROS, and reduced MAP-LC3 I-II conversion, and suppressed cell death. Blocking autophagy with a specific autophagy inhibitor 3-methyladenine (3-MA), the cytotoxic effect of this compound was attenuated.
CONCLUSION: Hirsutanol A has potent cytotoxic effect, and can induce autophagic cell death via increasing ROS production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20591217     DOI: 10.5732/cjc.009.10702

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  7 in total

1.  Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.

Authors:  Fangfang Zhong; You Yang; Danwei Ren; Sili Long; Xiang Qin; Jing Liu; Yan Zeng; Wenjian Lan; Wenzhe Ma; Wenjun Liu
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

2.  Isolation and structural elucidation of chondrosterins F-H from the marine fungus Chondrostereum sp.

Authors:  Hou-Jin Li; Ting Chen; Ying-Lu Xie; Wen-Dan Chen; Xiao-Feng Zhu; Wen-Jian Lan
Journal:  Mar Drugs       Date:  2013-02-22       Impact factor: 5.118

3.  Chondrosterins A-E, triquinane-type sesquiterpenoids from soft coral-associated fungus Chondrostereum sp.

Authors:  Hou-Jin Li; Ying-Lu Xie; Zhong-Liang Xie; Ying Chen; Chi-Keung Lam; Wen-Jian Lan
Journal:  Mar Drugs       Date:  2012-03-13       Impact factor: 6.085

4.  Induced marine fungus Chondrostereum sp. as a means of producing new sesquiterpenoids chondrosterins I and J by using glycerol as the carbon source.

Authors:  Hou-Jin Li; Wen-Han Jiang; Wan-Ling Liang; Jia-Xin Huang; Yu-Fei Mo; Yan-Qing Ding; Chi-Keung Lam; Xiao-Jun Qian; Xiao-Feng Zhu; Wen-Jian Lan
Journal:  Mar Drugs       Date:  2014-01-07       Impact factor: 5.118

Review 5.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

6.  Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS production.

Authors:  Fen Yang; Wen-Dan Chen; Rong Deng; Hui Zhang; Jun Tang; Ke-Wei Wu; Dan-Dan Li; Gong-Kan Feng; Wen-Jian Lan; Hou-Jin Li; Xiao-Feng Zhu
Journal:  J Transl Med       Date:  2013-02-08       Impact factor: 5.531

7.  Additional New Cytotoxic Triquinane-Type Sesquiterpenoids Chondrosterins K-M from the Marine Fungus Chondrostereum sp.

Authors:  Lei Huang; Wen-Jian Lan; Rong Deng; Gong-Kan Feng; Qing-Yan Xu; Zhi-Yu Hu; Xiao-Feng Zhu; Hou-Jin Li
Journal:  Mar Drugs       Date:  2016-08-26       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.